Cargando…

Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B

Background/Aims. Hepatitis B virus (HBV) can form immune complexes which may result in various types of glomerulonephritis (GN). However, proteinuria can occur because of other kidney diseases besides HBV-related GN (HBV-GN). The aim of this study is to elucidate the causes of proteinuria and report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Jeong-Ju, Lee, Jeong-Hoon, Yoon, Jung-Hwan, Lee, Minjong, Lee, Dong Hyeon, Cho, Yuri, Jang, Eun Sun, Cho, Eun Ju, Yu, Su Jong, Kim, Yoon Jun, Lee, Hyo-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348579/ https://www.ncbi.nlm.nih.gov/pubmed/25788940 http://dx.doi.org/10.1155/2015/126532

Ejemplares similares

Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
por: Cho, Eun Ju, et al.
Publicado: (2015)

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
por: Chung, Goh Eun, et al.
Publicado: (2017)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
por: Kim, Sun Woong, et al.
Publicado: (2022)

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
por: Cho, Hyeki, et al.
Publicado: (2016)

Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
por: Cho, Eun Ju, et al.
Publicado: (2016)

Association of Polymorphism in Pri-microRNAs-371-372-373 with the Occurrence of Hepatocellular Carcinoma in Hepatitis B Virus Infected Patients
por: Kwak, Min-Sun, et al.
Publicado: (2012)

Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
por: Chung, Sung Won, et al.
Publicado: (2018)

Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43
por: Cho, Yuri, et al.
Publicado: (2015)

Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
por: Han, Eugene, et al.
Publicado: (2020)

Current status and strategies for hepatitis B control in Korea
por: Cho, Eun Ju, et al.
Publicado: (2017)

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
por: Cho, Yuri, et al.
Publicado: (2015)

Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis
por: Yu, Su Jong, et al.
Publicado: (2017)

Comparison of the Effects of Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma between Patients with and without Extrahepatic Metastases
por: Yoo, Jeong-Ju, et al.
Publicado: (2014)

Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control comparative analysis
por: Yu, Su Jong, et al.
Publicado: (2016)

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma
por: Yu, Su Jong, et al.
Publicado: (2010)

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
por: Cho, Eun Ju, et al.
Publicado: (2012)

Quality of life correlation with socioeconomic status in Korean hepatitis-B patients: a cross sectional study
por: Kim, Seung Ju, et al.
Publicado: (2015)

Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
por: Cho, Young Youn, et al.
Publicado: (2020)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Kim, Minah, et al.
Publicado: (2021)

Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
por: Lee, Dong Hyeon, et al.
Publicado: (2017)

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
por: Jang, Heejoon, et al.
Publicado: (2023)

Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2021)

Does (18)F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?
por: Cho, Yuri, et al.
Publicado: (2014)

Noninvasive Assessment of Hepatic Fibrosis in Patients with Chronic Hepatitis B Viral Infection Using Magnetic Resonance Elastography
por: Lee, Jeong Eun, et al.
Publicado: (2014)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
por: Chun, Ho Soo, et al.
Publicado: (2021)

Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment
por: Chung, Goh Eun, et al.
Publicado: (2022)

Differential risk of 23 site‐specific incident cancers and cancer‐related mortality among patients with metabolic dysfunction‐associated fatty liver disease: a population‐based cohort study with 9.7 million Korean subjects
por: Chung, Goh Eun, et al.
Publicado: (2023)

Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype.
por: Kim, Young Sik, et al.
Publicado: (2002)

Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B
por: Yoo, Jeong-Ju, et al.
Publicado: (2020)

Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization
por: Cho, EunJu, et al.
Publicado: (2014)

Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B
por: Joo, Eun-Jeong, et al.
Publicado: (2021)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018)

The Degrees of Hepatocyte Cytoplasmic Expression of Hepatitis B Core Antigen correlate with Histologic Activity of Liver Disease in the Young Patients with Chronic Hepatitis B Infection
por: Kim, Tae Hyeon, et al.
Publicado: (2006)

Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
por: Yoo, Jeongin, et al.
Publicado: (2023)

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
por: Park, Jeayeon, et al.
Publicado: (2023)

Psychometric evaluation of the Korean version of the Hepatitis B Quality of Life Questionnaire
por: Jang, Yeonsoo, et al.
Publicado: (2019)

Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B
por: Jang, Yeonsoo, et al.
Publicado: (2017)

Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
por: Cho, Yuri, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4ont5sig06m9nqjnfoshn5nhoi